Skip to content
Loop Biz – Lifestyle
Author:
Santa Ana Bio, Inc.
Santa Ana Bio Announces First Subjects Dosed in Phase 1 Study of SAB01 to Treat Autoimmune Inflammatory Diseases
September 14, 2026